my 5445 and cyclic gmp
my 5445 has been researched along with cyclic gmp in 10 studies
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| dos Santos, IR; Duarte, ID; Ferreira, SH; Lorenzetti, BB | 1 |
| Duarte, ID; Ferreira, SH | 2 |
| Duarte, ID; Ferreira, SH; Lorenzetti, BB | 1 |
| Brazdil, R; Diocee, BK; Jordan, R; Souness, JE | 1 |
| Moncada, S; Palmer, RM; Radomski, MW | 1 |
| Ballou, LM; Edelmann, HM; Petritsch, C; Woscholski, R | 1 |
| Ko, FN; Kuo, SC; Lee, FY; Teng, CM; Wu, CC | 1 |
| Akamatsu, N; Inenaga, K; Yamashita, H | 1 |
| Barile, L; Giacomello, A; Lupi, F; Messina, E | 1 |
Other Studies
10 other study(ies) available for my 5445 and cyclic gmp
| Article | Year |
|---|---|
Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway.
Topics: Acyclic Monoterpenes; Analgesics; Animals; Arginine; Bucladesine; Cyclic AMP; Cyclic GMP; Dipyrone; Male; Monoterpenes; Nitric Oxide; Nociceptors; omega-N-Methylarginine; Phthalazines; Rats; Rats, Wistar; Terpenes | 1992 |
The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway.
Topics: Analgesia; Animals; Arginine; Brain; Carbachol; Cyclic GMP; Dinoprostone; Male; Molsidomine; Morphine; Nitric Oxide; Ornithine; Phthalazines; Rats; Rats, Wistar | 1992 |
The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release.
Topics: Analgesia; Animals; Arginine; Cyclic GMP; Male; Methylene Blue; Molsidomine; Morphine; Nitric Oxide; Ornithine; Phthalazines; Rats; Rats, Inbred Strains | 1991 |
Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Aorta, Thoracic; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Kinetics; Male; Methylene Blue; Muscle Relaxants, Central; Nitric Oxide; Phthalazines; Purinones; Pyridazines; Rats; Rats, Inbred Strains; Theophylline; Vinca Alkaloids | 1989 |
The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Aspirin; Blood Platelets; Collagen; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Humans; In Vitro Techniques; Nitric Oxide; Phthalazines; Platelet Adhesiveness; Purinones; Superoxide Dismutase; Thrombin | 1987 |
Activation of p70 S6 kinase and erk-encoded mitogen-activated protein kinases is resistant to high cyclic nucleotide levels in Swiss 3T3 fibroblasts.
Topics: 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Alprostadil; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Epidermal Growth Factor; Kinetics; Mice; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Nicotinic Acids; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Phthalazines; Protein Serine-Threonine Kinases; Ribosomal Protein S6 Kinases; Signal Transduction; Theophylline | 1995 |
YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Blood Platelets; Collagen; Cyclic AMP; Cyclic GMP; Dideoxyadenosine; Dose-Response Relationship, Drug; Enzyme Activation; Furans; Guanylate Cyclase; Hemoglobins; Humans; Indazoles; Nitric Oxide; Phosphodiesterase Inhibitors; Phthalazines; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Solubility; Thrombin; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Inhibitory effects of natriuretic peptides on vasopressin neurons mediated through cGMP and cGMP-dependent protein kinase in vitro.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Atrial Natriuretic Factor; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Electrophysiology; Enzyme Inhibitors; Isoquinolines; Male; Membrane Potentials; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Neurons; Phosphodiesterase Inhibitors; Phthalazines; Rats; Rats, Wistar; Second Messenger Systems; Supraoptic Nucleus; Vasopressins | 1993 |
L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Topics: Analgesics; Animals; Arginine; Carrageenan; Cyclic GMP; Dinoprostone; Hyperalgesia; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Phosphodiesterase Inhibitors; Phthalazines; Quinoxalines; Rats; Rats, Wistar; Signal Transduction | 2000 |
Cyclic nucleotides and neuroblastoma differentiation.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Neuroblastoma; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Phthalazines; Purinones; Time Factors | 2004 |